A Stanford oncologist discusses how to improve cancer diagnosis and treatment, including using predictive modeling, liquid biopsies and immunotherapy.
Ethical and legal issues accompany the potential benefits of using computer vision-based ambient intelligence in health care.
A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.
Stanford researchers investigate how to design better buildings that can improve their occupants’ health and productivity.
About half of astronauts could develop osteoporosis during a mission to Mars, a new study led by Stanford scientists has found.
Lasers, heat maps, fluorescence and real-time imaging help guide surgeons who are developing new ways to enhance precision brain surgery.
There are about 180 applications woven into the new Stanford Hospital's operations, making it a veritable laboratory for health care technology.
Researchers are working to develop a wearable sensor to measure stress, anxiety and depression based on changes in cortisol levels and other parameters.
Paul Costello has hosted scores of 1:2:1 podcast interviews with well-known authors, physicians, leaders and others. Here, he picks a few favorites.
This "In the Spotlight" features Ross Venook, a bioengineer who discusses his career path and his life as a busy father and husband outside of work.
The new Stanford Hospital is a high-tech place of healing for patients and families, and a place of innovation and well-being for employees and clinicians.
In this episode of "The Future of Everything," host Russ Altman and guest Ross Shachter discuss how AI can help radiologists with diagnosis accuracy.
Nephrology practices that are proactive rather than reactive provide better care at a lower cost, Stanford researchers find.
Surgeon Irene Wapnir and her colleagues developed a new technique for creating biological breast implants for women who have undergone a mastectomy.
In this 1:2:1 podcast, host Paul Costello discusses how to deliver the very best care for patients with Alpa Vyas, a Stanford Health Care vice president.
Screening more than 9,000 pairs of drugs helped Stanford and NIH scientists identify two drugs that synergize against a deadly childhood brain tumor.